October 25, 2024

Future Plans and Clinical Promise of Inebilizumab in Myasthenia Gravis: Richard Nowak, MD, MS – Neurology Live

October 21, 2024

Efficacy and safety of immunosuppressants and monoclonal antibodies in adults with myasthenia gravis: a systematic review and network meta-analysis – Journal of Translational Medicine

October 21, 2024

New discovery offers hope for vastly improved myasthenia gravis treatment – The Rockefeller University

October 19, 2024

Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker – Medpage Today

October 18, 2024

Therapeutic Potential of Self-Administered Subcutaneous Rozanolixizumab in Myasthenia Gravis: Rachana K. Gandhi Mehta, MBBS – Neurology Live